To Schedule an Appointment, Call Us Toll Free At 1.877.526.3457. Or, Send Us an E-mail for a Prompt Response.
If you or a loved one took ULORIC® (febuxostat) as a first line treatment for gout and suffered from any Major Adverse Cardiovascular Event including the following, you may qualify for compensation:
If you are a potential victim of Big Pharma’s pressure, please contact a dangerous drug attorney for a consultation.
Gout is type of arthritis characterized by a buildup of uric acid, leading to inflammation and swelling in your joints as well as the destruction of cartilage and bone. This is a chronic disease that affects approximately 8.3 million adults in the U.S. The number of medicines available to treat gout is limited, and there is an unmet need for treatments.
ULORIC is a prescription medicine used to treat gout. ULORIC was approved by the U.S. Food and Drug Administration in 2009 and works by lowering uric acid levels in the blood. As of February 2019, the U.S. Food and Drug Administration (FDA) concluded that ULORIC increased the risk of heart attack, stroke, and cardiac-related death. This conclusion is based on an in-depth review of results from a safety clinical trial. As a result, the FDA is updating the ULORIC prescribing information to require a Black Box Warning – their most prominent warning – and a new patient Medication Guide.
Reach out to a West Virginia Uloric lawyer today for a free consultation, or fill out our contact form so a member of our team can contact you.
Jan Dils, Attorneys at Law